148 related articles for article (PubMed ID: 10483692)
1. [Pharmacological and clinical effectiveness of a fixed phytogenic combination trembling poplar (Populus tremula), true goldenrod (Solidago virgaurea) and ash (Fraxinus excelsior) in mild to moderate rheumatic complaints].
Klein-Galczinsky C
Wien Med Wochenschr; 1999; 149(8-10):248-53. PubMed ID: 10483692
[TBL] [Abstract][Full Text] [Related]
2. A combination of Populus tremula, Solidago virgaurea and Fraxinus excelsior as an anti-inflammatory and antirheumatic drug. A short review.
von Kruedener S; Schneider W; Elstner EF
Arzneimittelforschung; 1995 Feb; 45(2):169-71. PubMed ID: 7710441
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of dihydrofolate reductase activity by alcoholic extracts from Fraxinus excelsior, Populus tremula and Solidago virgaurea.
Strehl E; Schneider W; Elstner EF
Arzneimittelforschung; 1995 Feb; 45(2):172-3. PubMed ID: 7710442
[TBL] [Abstract][Full Text] [Related]
4. Study of the anti-inflammatory activity of Populus tremula, Solidago virgaurea and Fraxinus excelsior.
el-Ghazaly M; Khayyal MT; Okpanyi SN; Arens-Corell M
Arzneimittelforschung; 1992 Mar; 42(3):333-6. PubMed ID: 1497695
[TBL] [Abstract][Full Text] [Related]
5. Effects of extracts from Populus tremula L., solidago virgaurea L. and Fraxinus excelsior L. on various myeloperoxidase systems.
von Kruedener S; Schneider W; Elstner EF
Arzneimittelforschung; 1996 Aug; 46(8):809-14. PubMed ID: 9125284
[TBL] [Abstract][Full Text] [Related]
6. New directions in symptomatic therapy for patients with osteoarthritis and rheumatoid arthritis.
Hochberg MC
Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):4-14. PubMed ID: 12528069
[TBL] [Abstract][Full Text] [Related]
7. Nabumetone: new preparation. Just another NSAID.
Prescrire Int; 2000 Apr; 9(46):43-6. PubMed ID: 11503785
[TBL] [Abstract][Full Text] [Related]
8. Antioxidative properties of alcoholic extracts from Fraxinus excelsior, Populus tremula and Solidago virgaurea.
Meyer B; Schneider W; Elstner EF
Arzneimittelforschung; 1995 Feb; 45(2):174-6. PubMed ID: 7710443
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerance of atrisin in degenerative and inflammatory joint disorders.
Sohail MT; Chaudhry MI; Usman MK; Mian T; Ishaq MN
Phytother Res; 2005 Apr; 19(4):365-8. PubMed ID: 16041739
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory effects of Phytodolor® (STW 1) and components (poplar, ash and goldenrod) on human monocytes/macrophages.
Bonaterra GA; Schwarzbach H; Kelber O; Weiser D; Kinscherf R
Phytomedicine; 2019 May; 58():152868. PubMed ID: 30831466
[TBL] [Abstract][Full Text] [Related]
11. Phytodolor--effects and efficacy of a herbal medicine.
Gundermann KJ; Müller J
Wien Med Wochenschr; 2007; 157(13-14):343-7. PubMed ID: 17704984
[TBL] [Abstract][Full Text] [Related]
12. [Reducing pain by oral enzyme therapy in rheumatic diseases].
Klein G; Kullich W
Wien Med Wochenschr; 1999; 149(21-22):577-80. PubMed ID: 10666820
[TBL] [Abstract][Full Text] [Related]
13. Methodology issues in the evaluation of NSAID in inflammatory rheumatic diseases.
Lequesne M
J Rheumatol Suppl; 1990 Feb; 20():25-8. PubMed ID: 2182853
[TBL] [Abstract][Full Text] [Related]
14. Six-month prospective study to monitor the treatment of rheumatic diseases with sustained-release flurbiprofen.
Rovenský J; Miceková D
Drugs Exp Clin Res; 2000; 26(1):19-24. PubMed ID: 10761533
[TBL] [Abstract][Full Text] [Related]
15. Blood pressure destabilization and edema among 8538 users of celecoxib, rofecoxib, and nonselective nonsteroidal antiinflammatory drugs (NSAID) and nonusers of NSAID receiving ordinary clinical care.
Wolfe F; Zhao S; Pettitt D
J Rheumatol; 2004 Jun; 31(6):1143-51. PubMed ID: 15170928
[TBL] [Abstract][Full Text] [Related]
16. An evidence-based approach to prescribing nonsteroidal antiinflammatory drugs. Third Canadian Consensus Conference.
Tannenbaum H; Bombardier C; Davis P; Russell AS;
J Rheumatol; 2006 Jan; 33(1):140-57. PubMed ID: 16331802
[TBL] [Abstract][Full Text] [Related]
17. The efficacy and cost effectiveness of N of 1 studies with diclofenac compared to standard treatment with nonsteroidal antiinflammatory drugs in osteoarthritis.
Pope JE; Prashker M; Anderson J
J Rheumatol; 2004 Jan; 31(1):140-9. PubMed ID: 14705233
[TBL] [Abstract][Full Text] [Related]
18. Droxicam: a pharmacological and clinical review of a new NSAID.
Jané F; Rodríguez de la Serna A
Eur J Rheumatol Inflamm; 1991; 11(4):3-9. PubMed ID: 1365488
[TBL] [Abstract][Full Text] [Related]
19. The cost effectiveness of rofecoxib and celecoxib in patients with osteoarthritis or rheumatoid arthritis.
Maetzel A; Krahn M; Naglie G
Arthritis Rheum; 2003 Jun; 49(3):283-92. PubMed ID: 12794781
[TBL] [Abstract][Full Text] [Related]
20. Celecoxib in osteoarthritis and rheumatoid arthritis: new preparation. As disappointing as rofecoxib.
Prescrire Int; 2001 Apr; 10(52):46-9. PubMed ID: 11718158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
